-+ 0.00%
-+ 0.00%
-+ 0.00%

Zymeworks Chief Scientific Officer Paul Andrew Moore Sells $1.04 Million in Common Shares

PUBT·11/16/2026 11:19:53
Listen to the news
Zymeworks Chief Scientific Officer Paul Andrew Moore Sells $1.04 Million in Common Shares
  • Zymeworks Chief Scientific Officer Paul Andrew Moore sold 39,741 common shares on Nov. 13, 2026.
  • Sales comprised 7,367 shares at $26.14, 7,374 shares at $26.09, and 25,000 shares at $26.04.
  • Moore also exercised stock options for 25,000 common shares at $5.82 per share.
  • Following the transactions, he directly held 33,756 common shares and 175,000 stock options.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zymeworks Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001938192-26-000007), on November 16, 2026, and is solely responsible for the information contained therein.